Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Innovative Journal of Pediatrics
  4. Articles

  5. Oral Zinc Sulfate as Adjuvant Treatment in Children With Nephrolithiasis: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
  6. Scopus by Title (Ref)

Innovative Journal of Pediatrics

The Scientific Journal of Growth & Development Research Center

Home
Accepted ManuscriptsCurrent IssueAll IssuesIn Press ArticlesSearch
Instructions
Journal InformationBoards and CommitteesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormAnnouncementSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. The role of zinc in urinary stone disease

- Negri A. , et al.

2. Medical and dietary interventions for preventing recurrent urinary stones in children

- Kern A. , et al.

3. Zinc as a Contributing Factor in Lithogenesis: Not Yet Ready for the Clinic

- Ferraro P. , et al.

4. Serum zinc levels in children with and without nephrolithiasis

- Yousefichaijan P. , et al.

5. Clinical signs, causes, and risk factors of pediatric kidney stone disease: A hospital-based case-control study

- Yousefichaijan P. , et al.

HomeInstructionsAPC

Articles

  • Accepted Manuscripts
  • Current Issue
  • All Issues
  • In Press Articles
  • Search

About Journal

  • Journal Information
  • Boards and Committees
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Announcement
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.